Efficacy of beta blockers in elderly patients with MI

January 1999
American Family Physician;1/15/1999, Vol. 59 Issue 2, p464
Academic Journal
Presents an abstract of the study `National Use and Effectiveness of Beta-Blockers for the Treatment of Elderly Patients After Acute Myocardial Infarction. National Cooperative Cardiovascular Project,' by H. M. Krumholz, et al, from the `Journal of American Medical Association' dated August 19, 1998.


Related Articles

  • Beta blockers vs. newer glaucoma agents: How do the pieces fit? Mundorf, Thomas K. // Ophthalmology Times;09/01/97 Supplement, Vol. 22 Issue 17, p2 

    Presents a transcript of the roundtable discussion on the changing role of beta blockers as first line therapy in the management of open-angle glaucoma at the 1997 meeting of the Association for Research in Vision and Ophthalmology. Improvements on nonselective beta blockers; Safeness of the...

  • Beta-blockers after MI: Seriously underused. Pinkowish, Mary Desmond // Patient Care;2/28/1997, Vol. 31 Issue 4, p29 

    Cites the findings of a study on the use of beta-blockers in postmyocardial infarction therapy in the United States. Beneficial effects of beta-blockers in postmyocardial infarction therapy; Underusage of beta-blockers in postmyocardial infarction therapy; Recommendation to avoid adverse...

  • Treatment of Thyrotoxic Storm with Intravenous Administration of Propranolol. Das, Gopal; Krieger, Michael // Annals of Internal Medicine;May69, Vol. 70 Issue 5, p985 

    Describes the case of a thyrotoxic storm which was refractory to conventional therapy but responded immediately to beta adrenergic blockade by means of intravenous administration of propranolol. Medical history of the patient studied; Symptoms reported by the patient; Factor attributed to the...

  • Two patients with schizophrenic-like psychosis after treatment with beta-adrenergic blockers. Steinert, J.; Pugh, C.R. // British Medical Journal;3/24/1979, Vol. 1 Issue 6166, p790 

    Focuses on patients suffering from psychotic illness during treatment with beta-adrenergic blockers in London, England. Use of the drug for cardiovascular illness; Emphasis on the dosage of the drug; Improvement on the neuroleptic medications.

  • Utility of antimuscarinic drugs. Wolstenholme, Roger J. // BMJ: British Medical Journal;2/1/2014, Vol. 348 Issue 7943, p23 

    A letter to the editor is presented in response to the article "Effect of ß Blockers on Mortality After Myocardial Infarction in Adults With COPD: Population Based Cohort study of UK Electronic Healthcare Records," by JK Quint and colleagues in the November 22, 2013 issue.

  • Why Aren't We Using Beta Blockers After Acute MI? Weichel, Amy S. // American Family Physician;10/15/2000, Vol. 62 Issue 8, p1771 

    Editorial. Highlights the underutilization of therapy with beta blockers after acute myocardial infarction (MI). Effectiveness of beta blockers in reducing mortality after acute MI; Categorization of interventions based on effectiveness in promoting behavior changes in physicians.

  • Topical, systemic beta-blockers don't work together. Guttman, Cheryl; Schuman, Joel S. // Ophthalmology Times;04/15/2000, Vol. 25 Issue 8, p80 

    Presents information on a study which investigated the interaction between topical and systemic beta-blockers for the treatment of ocular hypertension or glaucoma. Efficacy of brimonidine as an intraocular pressure-lowering treatment; Pharmacodynamic interaction between topical and systemic...

  • Comparison of effects of propranolol and metoprolol on airways obstruction in chronic bronchitis. Sinclair, D.J.M. // British Medical Journal;1/20/1979, Vol. 1 Issue 6157, p168 

    Presents the treatment for hypertension and angina pectoris by beta-adrenergic blockade. Effects of metoprolol and propranolol on the airways of patients; Emphasis on the dosage of the drugs administered; Discussions on the sympathetic activity in patients.

  • J-CHF: Small doses of carvedilol per day as effective as higher recommended doses. Rusk, Judith // Cardiology Today;Jan2010, Vol. 13 Issue 1, p17 

    The article discusses the results of the Japanese-Chronic Heart (J-CHF) study which found that small doses of beta-blocker carvedilol are as beneficial to patients as higher recommended doses.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics